313 related articles for article (PubMed ID: 21541368)
1. A yeast model of FUS/TLS-dependent cytotoxicity.
Ju S; Tardiff DF; Han H; Divya K; Zhong Q; Maquat LE; Bosco DA; Hayward LJ; Brown RH; Lindquist S; Ringe D; Petsko GA
PLoS Biol; 2011 Apr; 9(4):e1001052. PubMed ID: 21541368
[TBL] [Abstract][Full Text] [Related]
2. Molecular determinants and genetic modifiers of aggregation and toxicity for the ALS disease protein FUS/TLS.
Sun Z; Diaz Z; Fang X; Hart MP; Chesi A; Shorter J; Gitler AD
PLoS Biol; 2011 Apr; 9(4):e1000614. PubMed ID: 21541367
[TBL] [Abstract][Full Text] [Related]
3. A Genetic Screen for Human Genes Suppressing FUS Induced Toxicity in Yeast.
Hayden E; Chen S; Chumley A; Xia C; Zhong Q; Ju S
G3 (Bethesda); 2020 Jun; 10(6):1843-1852. PubMed ID: 32276960
[TBL] [Abstract][Full Text] [Related]
4. FUS/TLS forms cytoplasmic aggregates, inhibits cell growth and interacts with TDP-43 in a yeast model of amyotrophic lateral sclerosis.
Kryndushkin D; Wickner RB; Shewmaker F
Protein Cell; 2011 Mar; 2(3):223-36. PubMed ID: 21452073
[TBL] [Abstract][Full Text] [Related]
5. Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic lateral sclerosis.
Kwiatkowski TJ; Bosco DA; Leclerc AL; Tamrazian E; Vanderburg CR; Russ C; Davis A; Gilchrist J; Kasarskis EJ; Munsat T; Valdmanis P; Rouleau GA; Hosler BA; Cortelli P; de Jong PJ; Yoshinaga Y; Haines JL; Pericak-Vance MA; Yan J; Ticozzi N; Siddique T; McKenna-Yasek D; Sapp PC; Horvitz HR; Landers JE; Brown RH
Science; 2009 Feb; 323(5918):1205-8. PubMed ID: 19251627
[TBL] [Abstract][Full Text] [Related]
6. FUS/TLS-immunoreactive neuronal and glial cell inclusions increase with disease duration in familial amyotrophic lateral sclerosis with an R521C FUS/TLS mutation.
Suzuki N; Kato S; Kato M; Warita H; Mizuno H; Kato M; Shimakura N; Akiyama H; Kobayashi Z; Konno H; Aoki M
J Neuropathol Exp Neurol; 2012 Sep; 71(9):779-88. PubMed ID: 22878663
[TBL] [Abstract][Full Text] [Related]
7. Arginine methylation by PRMT1 regulates nuclear-cytoplasmic localization and toxicity of FUS/TLS harbouring ALS-linked mutations.
Tradewell ML; Yu Z; Tibshirani M; Boulanger MC; Durham HD; Richard S
Hum Mol Genet; 2012 Jan; 21(1):136-49. PubMed ID: 21965298
[TBL] [Abstract][Full Text] [Related]
8. Intranuclear aggregation of mutant FUS/TLS as a molecular pathomechanism of amyotrophic lateral sclerosis.
Nomura T; Watanabe S; Kaneko K; Yamanaka K; Nukina N; Furukawa Y
J Biol Chem; 2014 Jan; 289(2):1192-202. PubMed ID: 24280224
[TBL] [Abstract][Full Text] [Related]
9. Divergent roles of ALS-linked proteins FUS/TLS and TDP-43 intersect in processing long pre-mRNAs.
Lagier-Tourenne C; Polymenidou M; Hutt KR; Vu AQ; Baughn M; Huelga SC; Clutario KM; Ling SC; Liang TY; Mazur C; Wancewicz E; Kim AS; Watt A; Freier S; Hicks GG; Donohue JP; Shiue L; Bennett CF; Ravits J; Cleveland DW; Yeo GW
Nat Neurosci; 2012 Nov; 15(11):1488-97. PubMed ID: 23023293
[TBL] [Abstract][Full Text] [Related]
10. Aggregation of ALS-linked FUS mutant sequesters RNA binding proteins and impairs RNA granules formation.
Takanashi K; Yamaguchi A
Biochem Biophys Res Commun; 2014 Sep; 452(3):600-7. PubMed ID: 25173930
[TBL] [Abstract][Full Text] [Related]
11. RNA-binding ability of FUS regulates neurodegeneration, cytoplasmic mislocalization and incorporation into stress granules associated with FUS carrying ALS-linked mutations.
Daigle JG; Lanson NA; Smith RB; Casci I; Maltare A; Monaghan J; Nichols CD; Kryndushkin D; Shewmaker F; Pandey UB
Hum Mol Genet; 2013 Mar; 22(6):1193-205. PubMed ID: 23257289
[TBL] [Abstract][Full Text] [Related]
12. A Drosophila model of FUS-related neurodegeneration reveals genetic interaction between FUS and TDP-43.
Lanson NA; Maltare A; King H; Smith R; Kim JH; Taylor JP; Lloyd TE; Pandey UB
Hum Mol Genet; 2011 Jul; 20(13):2510-23. PubMed ID: 21487023
[TBL] [Abstract][Full Text] [Related]
13. The RNA-binding protein FUS/TLS undergoes calcium-mediated nuclear egress during excitotoxic stress and is required for
Tischbein M; Baron DM; Lin YC; Gall KV; Landers JE; Fallini C; Bosco DA
J Biol Chem; 2019 Jun; 294(26):10194-10210. PubMed ID: 31092554
[TBL] [Abstract][Full Text] [Related]
14. Novel FUS/TLS mutations and pathology in familial and sporadic amyotrophic lateral sclerosis.
Hewitt C; Kirby J; Highley JR; Hartley JA; Hibberd R; Hollinger HC; Williams TL; Ince PG; McDermott CJ; Shaw PJ
Arch Neurol; 2010 Apr; 67(4):455-61. PubMed ID: 20385912
[TBL] [Abstract][Full Text] [Related]
15. Expression of human FUS/TLS in yeast leads to protein aggregation and cytotoxicity, recapitulating key features of FUS proteinopathy.
Fushimi K; Long C; Jayaram N; Chen X; Li L; Wu JY
Protein Cell; 2011 Feb; 2(2):141-9. PubMed ID: 21327870
[TBL] [Abstract][Full Text] [Related]
16. ALS mutations of FUS suppress protein translation and disrupt the regulation of nonsense-mediated decay.
Kamelgarn M; Chen J; Kuang L; Jin H; Kasarskis EJ; Zhu H
Proc Natl Acad Sci U S A; 2018 Dec; 115(51):E11904-E11913. PubMed ID: 30455313
[TBL] [Abstract][Full Text] [Related]
17. Widespread FUS mislocalization is a molecular hallmark of amyotrophic lateral sclerosis.
Tyzack GE; Luisier R; Taha DM; Neeves J; Modic M; Mitchell JS; Meyer I; Greensmith L; Newcombe J; Ule J; Luscombe NM; Patani R
Brain; 2019 Sep; 142(9):2572-2580. PubMed ID: 31368485
[TBL] [Abstract][Full Text] [Related]
18. ALS mutations in TLS/FUS disrupt target gene expression.
Coady TH; Manley JL
Genes Dev; 2015 Aug; 29(16):1696-706. PubMed ID: 26251528
[TBL] [Abstract][Full Text] [Related]
19. Intracellular localization and splicing regulation of FUS/TLS are variably affected by amyotrophic lateral sclerosis-linked mutations.
Kino Y; Washizu C; Aquilanti E; Okuno M; Kurosawa M; Yamada M; Doi H; Nukina N
Nucleic Acids Res; 2011 Apr; 39(7):2781-98. PubMed ID: 21109527
[TBL] [Abstract][Full Text] [Related]
20. TDP-43 and FUS/TLS: sending a complex message about messenger RNA in amyotrophic lateral sclerosis?
Strong MJ; Volkening K
FEBS J; 2011 Oct; 278(19):3569-77. PubMed ID: 21810174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
